Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myasthenia Gravis ll: Pathophysiology
Rheumatic Heart Disease III: Medical Management
Myasthenia Gravis: Overview and Treatment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 5, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Sarah L Mackie1, Christian D Mallen
1National Institute for Health Research-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK.
No abstract available in PubMed .